Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Zentralbl Gynakol ; 115(11): 503-7, 1993.
Artículo en Alemán | MEDLINE | ID: mdl-8296497

RESUMEN

We present a case of primary malignant melanoma of the cervix uteri. The prognosis of this very rare tumor is rather poor. Radical abdominal hysterectomy combined with partial colpectomy, bilateral adnexectomy and dissection of the pelvine lymph-nodes seems to improve the clinical outcome even if an additional brachytherapy is added.


Asunto(s)
Melanoma/patología , Neoplasias del Cuello Uterino/patología , Cuello del Útero/patología , Epitelio/patología , Femenino , Humanos , Melanoma/cirugía , Persona de Mediana Edad , Metástasis de la Neoplasia , Recurrencia Local de Neoplasia/patología , Recurrencia Local de Neoplasia/cirugía , Reoperación , Neoplasias del Cuello Uterino/cirugía
2.
Fortschr Med ; 94(33): 1900-6, 1976 Nov 18.
Artículo en Alemán | MEDLINE | ID: mdl-825425

RESUMEN

Numerous interactions between hormonal contraceptives and liver function have been described. Changed laboratory results do not represent obligatory pathologic conditions or hepatotoxi effects. Some of these changed results are transient, suggesting that liver cells are capable of adaptation. The use of oral contraceptives is contraindicated in the following liver diseases: - recurrent intrahepatic cholestasis (recurrent jaundice of pregnancy, Dubin-Johnson syndrome, Rotor syndrome); - acute disturbances of liver function. In general it is recommended that hormonal contraceptives should not be used by patients with biliary cirrhosis although some authors have stated that chronic disturbances of liver function did not appear to be aggravated by these agents. Impairment of carbohydrate and lipid metabolism needs careful control of the laboratory tests concerned. Due to its low frequency the increased risk of gallstones does not necessitate the withdrawal of the medication. Up to now the interrelationship between the use of contraceptive steroids and the induction of hepatic tumours has not been proven.


Asunto(s)
Anticonceptivos Orales/efectos adversos , Hígado/efectos de los fármacos , 5-Aminolevulinato Sintetasa/sangre , Angiotensina II/sangre , Proteínas Sanguíneas , Femenino , Proteínas Fetales , Humanos , Yodo/sangre , Hígado/enzimología , Renina/sangre , Sulfobromoftaleína/sangre , Proteínas de Unión a Tiroxina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA